It says both drugs cause dose-dependent gastrointestinal effects such as nausea, vomiting, diarrhea, and constipation, and that combining them typically raises the frequency and severity of adverse events without additional therapeutic gain
For weight management, patients typically start at 0.25 mg weekly and increase by 0.25 mg each week until reaching a therapeutic doseusually 1.0 to 2.4 mg
J Environ Occup Med 25;33(1):712 Renaud CO, Ziros PG, Chartoumpekis DV, Bongiovanni M, Sykiotis GP (2019) Keap1/Nrf2 signaling: a new player in thyroid pathophysiology and thyroid cancer
Eso puede ser peligroso, especialmente si el formato es inyectable
Common cellular and molecular mechanisms in obesity and drug addiction